Pyxus International Stock Earnings Reports

Pyxus reported a strong fiscal 2025 driven by pricing, selective volume growth and disciplined working capital. Full-year sales increased 22% to $2.5 billion; gross profit rose 10% to $343 million; operating income increased 12% to $153 million; net income was $15 million (vs. $3M prior year); adjusted EBITDA was $208 million. Volumes rose 3% by sourcing additional tobacco from Africa and Asia and accelerating shipments to offset South American crop disruptions. The company generated $152 million of adjusted free cash flow for the year and reduced long-term senior debt by $143 million since March 1, 2024 (retiring $65M in FY25), bringing leverage down from 4.8x to 3.7x—the lowest in over a decade. Year-end inventory fell to $762 million (from $932M), with only $8M of uncommitted inventory. Pyxus achieved SBTi validation for near-term emissions targets and reported a 16% reduction in indirect emissions since FY2021. Guidance for fiscal 2026: sales $2.3B–$2.5B and adjusted EBITDA $205M–$235M, with results expected to be weighted to the second half due to replenishment and shipment timing; management expects larger crops and higher margins but potentially lower selling prices. Key investor considerations: continued margin expansion potential, improved credit metrics and interest coverage (1.6x), seasonal working capital needs that may increase net borrowings in H1 as inventory is replenished, and exposure to trade/tariff developments and pricing normalization as crops recover.